These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31462766)

  • 61. Antidepressants effects of Rhodiola capsule combined with sertraline for major depressive disorder: A randomized double-blind placebo-controlled clinical trial.
    Gao L; Wu C; Liao Y; Wang J
    J Affect Disord; 2020 Mar; 265():99-103. PubMed ID: 32090788
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients?
    Trivedi MH; Rush AJ; Carmody TJ; Donahue RM; Bolden-Watson C; Houser TL; Metz A
    J Clin Psychiatry; 2001 Oct; 62(10):776-81. PubMed ID: 11816866
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An electroencephalographic signature predicts antidepressant response in major depression.
    Wu W; Zhang Y; Jiang J; Lucas MV; Fonzo GA; Rolle CE; Cooper C; Chin-Fatt C; Krepel N; Cornelssen CA; Wright R; Toll RT; Trivedi HM; Monuszko K; Caudle TL; Sarhadi K; Jha MK; Trombello JM; Deckersbach T; Adams P; McGrath PJ; Weissman MM; Fava M; Pizzagalli DA; Arns M; Trivedi MH; Etkin A
    Nat Biotechnol; 2020 Apr; 38(4):439-447. PubMed ID: 32042166
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.
    Brunoni AR; Kemp AH; Shiozawa P; Cordeiro Q; Valiengo LC; Goulart AC; Coprerski B; Lotufo PA; Brunoni D; Perez AB; Fregni F; Benseñor IM
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1530-40. PubMed ID: 23615118
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
    Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
    J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
    Amsterdam JD; Williams D; Michelson D; Adler LA; Dunner DL; Nierenberg AA; Reimherr FW; Schatzberg AF
    Neuropsychobiology; 2009; 59(4):227-33. PubMed ID: 19571597
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
    Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN
    CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.
    Abbasi SH; Hosseini F; Modabbernia A; Ashrafi M; Akhondzadeh S
    J Affect Disord; 2012 Dec; 141(2-3):308-14. PubMed ID: 22516310
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study.
    Blumenthal JA; Sherwood A; Babyak MA; Watkins LL; Smith PJ; Hoffman BM; O'Hayer CV; Mabe S; Johnson J; Doraiswamy PM; Jiang W; Schocken DD; Hinderliter AL
    J Am Coll Cardiol; 2012 Sep; 60(12):1053-63. PubMed ID: 22858387
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reward dysfunction in major depression: multimodal neuroimaging evidence for refining the melancholic phenotype.
    Foti D; Carlson JM; Sauder CL; Proudfit GH
    Neuroimage; 2014 Nov; 101():50-8. PubMed ID: 24996119
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reinforcement Learning Disruptions in Individuals With Depression and Sensitivity to Symptom Change Following Cognitive Behavioral Therapy.
    Brown VM; Zhu L; Solway A; Wang JM; McCurry KL; King-Casas B; Chiu PH
    JAMA Psychiatry; 2021 Oct; 78(10):1113-1122. PubMed ID: 34319349
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Psychomotor changes in major depressive disorder during sertraline treatment.
    Schrijvers D; Maas YJ; Pier MP; Madani Y; Hulstijn W; Sabbe BG
    Neuropsychobiology; 2009; 59(1):34-42. PubMed ID: 19270462
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intrinsic reward circuit connectivity profiles underlying symptom and quality of life outcomes following antidepressant medication: a report from the iSPOT-D trial.
    Fischer AS; Holt-Gosselin B; Fleming SL; Hack LM; Ball TM; Schatzberg AF; Williams LM
    Neuropsychopharmacology; 2021 Mar; 46(4):809-819. PubMed ID: 33230268
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Spontaneous thought-related network connectivity predicts sertraline effect on major depressive disorder.
    Hsu LM; Lane TJ; Wu CW; Lin CY; Yeh CB; Kao HW; Lin CP
    Brain Imaging Behav; 2021 Aug; 15(4):1705-1717. PubMed ID: 32710339
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hypothalamus-anchored resting brain network changes before and after sertraline treatment in major depression.
    Yang R; Zhang H; Wu X; Yang J; Ma M; Gao Y; Liu H; Li S
    Biomed Res Int; 2014; 2014():915026. PubMed ID: 24772438
    [TBL] [Abstract][Full Text] [Related]  

  • 76. EEG Biomarkers to Predict Response to Sertraline and Placebo Treatment in Major Depressive Disorder.
    Oakley T; Coskuner J; Cadwallader A; Ravan M; Hasey G
    IEEE Trans Biomed Eng; 2023 Mar; 70(3):909-919. PubMed ID: 36094967
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Signed Reward Prediction Errors in the Ventral Striatum Drive Episodic Memory.
    Calderon CB; De Loof E; Ergo K; Snoeck A; Boehler CN; Verguts T
    J Neurosci; 2021 Feb; 41(8):1716-1726. PubMed ID: 33334870
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reward processing in major depressive disorder and prediction of treatment response - Neuropharm study.
    Brandt IM; Köhler-Forsberg K; Ganz M; Ozenne B; Jorgensen MB; Poulsen A; Knudsen GM; Frokjaer VG; Fisher PM
    Eur Neuropsychopharmacol; 2021 Mar; 44():23-33. PubMed ID: 33455816
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study.
    Bekhbat M; Li Z; Mehta ND; Treadway MT; Lucido MJ; Woolwine BJ; Haroon E; Miller AH; Felger JC
    Mol Psychiatry; 2022 Oct; 27(10):4113-4121. PubMed ID: 35927580
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial.
    Masoudi M; Ansari S; Kashani L; Tavolinejad H; Hossein Rashidi B; Esalatmanesh S; Ghazizadeh-Hashemi M; Noorbala AA; Akhondzadeh S
    Int Clin Psychopharmacol; 2021 Sep; 36(5):238-243. PubMed ID: 34030169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.